{"version":"1.0","type":"link","title":"Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma.","author_name":"Chen M 외","author_url":"https://prs-insight.online/author/Chen%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167158","thumbnail_width":1200,"thumbnail_height":630}